Evogene Ltd. (TLV:EVGN)
434.60
+0.20 (0.05%)
Aug 25, 2025, 4:39 PM IDT
Evogene Employees
Evogene had 117 employees as of December 31, 2024. The number of employees decreased by 25 or -17.61% compared to the previous year.
Employees
117
Change (1Y)
-25
Growth (1Y)
-17.61%
Revenue / Employee
271.96K ILS
Profits / Employee
-410.45K ILS
Market Cap
38.23M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117 | -25 | -17.61% |
Dec 31, 2023 | 142 | 5 | 3.65% |
Dec 31, 2022 | 137 | -4 | -2.84% |
Dec 31, 2021 | 141 | 10 | 7.63% |
Dec 31, 2020 | 131 | -12 | -8.39% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Teva Pharmaceutical Industries | 35,686 |
Danel (Adir Yeoshua) | 4,290 |
Kamada | 420 |
Bait Bakfar | 227 |
SofWave Medical | 126 |
BrainsWay | 120 |
Novolog (Pharm-Up 1966) | 936 |
Ilex Medical | 178 |
Evogene News
- 7 days ago - Evogene Q2 2025 Earnings Preview - Seeking Alpha
- 7 days ago - Preview: Evogene's Earnings - Benzinga
- 13 days ago - Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - PRNewsWire
- 27 days ago - Evogene Schedules Second Quarter 2025 Financial Results Release - PRNewsWire
- 6 weeks ago - Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL - PRNewsWire
- 2 months ago - Evogene Announces Completion of First-In-Class Foundation Model for Generative Molecule Design, Developed in Collaboration with Google Cloud - PRNewsWire
- 3 months ago - Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Evogene GAAP EPS of -$0.38, revenue of $2.44M - Seeking Alpha